Skip to main content

Advertisement

Table 2 Distribution of clinical centers where the 6031 enrolled nasopharyngeal carcinoma patients received a biopsy and therapy

From: A new prognostic histopathologic classification of nasopharyngeal carcinoma

Center for biopsy Center for therapy Number of cases
Department of Pathology, Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou, Guangdong, China Department of Radiation Oncology, SYSUCC 4329
Department of Pathology, multiple local centers in Guangdong, China Department of Radiation Oncology, SYSUCC 504
Department of Pathology, Guangxi Medical University Cancer Center, Nanning, Guangxi, China Department of Radiation Oncology, Guangxi Medical University Cancer Center 204
Department of Pathology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences (CAMS), Beijing, China Department of Radiation Oncology, Cancer Hospital, CAMS 100
Department of Pathology, The Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China Department of Radiation Oncology, The Affiliated Hospital of Bengbu Medical College 113
Department of Pathology, Hunan Provincial Cancer Hospital, Changsha, Hunan, China Department of Radiation Oncology, Hunan Provincial Cancer Hospital 130
Department of Pathology, Fujian Provincial Tumor Hospital, Fuzhou, Fujian, China Department of Radiation Oncology, Fujian Provincial Tumor Hospital 47
Department of Anatomical and Cellular Pathology, Faculty of Medicine, the Chinese University of Hong Kong (CUHK), Hong Kong, China Department of Clinical Oncology, CUHK 207
Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan Department of Otolaryngology, National Taiwan University Hospital 211
Department of Pathology, Singapore General Hospital, Singapore, Singapore Department of Radiation Oncology, National Cancer Center, Singapore 186